Cargando…
Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis
The purpose of this meta-analysis was to investigate whether bisphosphonates are a key therapy for bone metastases in lung cancer, breast cancer, and prostate cancer by comparing all randomized controlled trials that appraised the effects of bisphosphonates on risk of skeletal-related events (SREs)....
Autores principales: | Liu, Jing, Huang, Wenhui, Zhou, Ruoyu, Jia, Shuting, Tang, Wenru, Luo, Ying, Zhang, Jihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652817/ https://www.ncbi.nlm.nih.gov/pubmed/26579808 http://dx.doi.org/10.1097/MD.0000000000002014 |
Ejemplares similares
-
Efficacy and safety of bisphosphonates on childhood osteoporosis
secondary to chronic illness or its treatment: a meta-analysis
por: Zhao, Huawei, et al.
Publicado: (2022) -
The incidence and relative risk of adverse events in patients treated
with bisphosphonate therapy for breast cancer: a systematic review and
meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2019) -
Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials
por: Yang, Yan, et al.
Publicado: (2018) -
Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Lu, Fei, et al.
Publicado: (2021) -
Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer
por: Wu, Jing, et al.
Publicado: (2017)